Start the conversation
Marijuana became legal in Canada on Oct. 17, and that's just one big reason to know more about the biggest pot stocks to watch this week.
Up to eight U.S. states will vote on ballot measures related to marijuana this fall. New Jersey's legislature is also considering legalizing the plant. New Jersey will be the second largest state to legalize weed after California. Cannabis is quickly becoming legal in the United States via state vote or legislative action.
By 2021, legal marijuana could become a powerhouse industry, worth a whopping $24.5 billion in the U.S. alone. That's more than the double the current value of the legal marijuana industry.
You see, legalization leads to more people buying cannabis; more companies growing, distributing, and selling it; and more companies experimenting with the medical benefits of cannabis.
Legalized cannabis could be an explosive catalyst, and we're bringing you the top pot stocks to watch in October to help you cash in.
Pot Stocks to Watch This Week, No. 2: GW Pharmaceuticals
United Kingdom-based pharmaceutical manufacturer GW Pharmaceuticals Plc. (NASDAQ: GWPH) targets the development of marijuana-based experimental drugs for specific conditions in its business.
GW's Epidiolex drug is focused on treatment for two rare forms of epilepsy. Researchers at GW are currently investigating its use for two other conditions that cause seizures.
From Biggest Foe to Biggest Advocate: Former Speaker John Boehner voices his full support for marijuana legalization – and reveals the three key events that will transform the industry forever. Watch now…
In late June 2018, the U.S. Food and Drug Administration (FDA) approved Epidiolex for patients with Dravet Syndrome and Lennox-Gastaut Syndrome. The approval was the first time the FDA had approved a drug that used a cannabis-derived substance.
Money Morning Defense and Tech Specialist Michael A. Robinson forecasts that Epidiolex could generate revenue of up to $1.7 billion by 2026.
GWPH is currently trading at $133.88, and analysts project that it could trade for $178.33 in the next 12 months.
But the profit opportunity from this next pot stock to watch could be even bigger…